Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 0.56 is 70% below its 5-year average of 1.84, near the low end of its 5-year range (0.55–6.13).
As of the fiscal period ended Tuesday, June 30, 2026. 56.46% below its 12-month average of 1.28.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.56.
CURRENT RATIO
0.56
CURRENT RATIO AVG TTM
1.28
CURRENT RATIO AVG 3Y
1.33
CURRENT RATIO AVG 5Y
1.84
CURRENT RATIO AVG 10Y
3.00
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-56.46%
CURRENT VS 3Y AVG
-58.05%
CURRENT VS 5Y AVG
-69.71%
CURRENT VS 10Y AVG
-81.45%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.76
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
-85.19%
vs the sector median at left
Market Cap
$6.74M
Current Ratio
2.61
TTM Avg
3.40
3Y Avg
4.86
5Y Avg
5.09
Market Cap
$7.07M
Current Ratio
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.60M
Current Ratio
0.70
TTM Avg
2.00
3Y Avg
1.31
5Y Avg
1.04
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Exicure, Inc. (XCUR) | $6.88M | 0.56 | 1.28 | 1.33 | 1.84 |
| Bolt Biotherapeutics, Inc. (BOLT)vs › | $6.74M | 2.61 | 3.40 | 4.86 | 5.09 |
| KALA BIO, Inc. (KALA)vs › | $7.04M | 6.88 | 3.46 | 4.15 | 4.60 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.07M | 45.95 | 58.73 | 40.89 | 40.89 |
| Skye Bioscience, Inc. (SKYE)vs › | $7.12M | 0.95 | 9.81 | 5.30 | 4.51 |
| Longeveron Inc. (LGVN)vs › | $7.15M | 2.63 | 4.46 | 3.65 | 4.69 |
| Biomerica, Inc. (BMRA)vs › | $6.61M | 1.62 | 2.21 | 3.63 | 4.38 |
| Ensysce Biosciences, Inc. (ENSC)vs › | $6.60M | 0.70 | 2.00 | 1.31 | 1.04 |
| Aclarion, Inc. (ACON)vs › | $6.60M | 16.20 | 7.76 | 4.60 | 3.08 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.58M | 10.21 | 3.61 | 3.34 | 4.20 |
Current Ratio
0.56
Quick Ratio
0.56
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 0.56 |
| 2026-03-31 | 0.79 |
| 2025-12-31 | 1.19 |
| 2025-09-30 | 1.96 |
| 2025-06-30 | 1.89 |
| 2025-03-31 | 2.91 |
| 2024-12-31 | 4.45 |
| 2024-09-30 | 0.71 |
| 2024-06-30 | 0.61 |
| 2024-03-31 | 0.55 |
| 2023-12-31 | 0.81 |
| 2023-09-30 | 1.39 |
| 2023-06-30 | 2.56 |
| 2023-03-31 | 4.13 |
| 2022-12-31 | 6.13 |
| 2022-09-30 | 0.67 |
| 2022-06-30 | 1.26 |
| 2022-03-31 | 1.37 |
| 2021-12-31 | 1.28 |
| 2021-09-30 | 2.92 |
| 2021-06-30 | 4.76 |
| 2021-03-31 | 5.80 |
| 2020-12-31 | 6.29 |
| 2020-09-30 | 7.68 |
| 2020-06-30 | 6.22 |
| 2020-03-31 | 4.99 |
| 2019-12-31 | 3.63 |
| 2019-09-30 | 8.67 |
| 2019-06-30 | 2.32 |
| 2019-03-31 | 2.87 |
| 2018-12-31 | 13.54 |
| 2018-09-30 | 3.69 |
| 2018-06-30 | 4.24 |
| 2018-03-31 | 7.64 |
| 2017-12-31 | 8.24 |
| 2017-09-30 | 2.31 |
| 2017-06-30 | 0.93 |
| 2017-04-01 | 0.00 |
| 2016-12-31 | 1.65 |
| 2016-09-30 | 0.00 |
| 2016-06-30 | 0.00 |
| 2016-03-31 | 0.00 |
